Multiple alloantibodies after transfusion in an infant treated with infliximab [13]

New England Journal of Medicine

Volumn 357, Issue 20, 2007, Pages 2092-2093

  Tyler, Lisa N ^a   Harville, Terry O ^a   Blackall, Douglas P ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; INFLIXIMAB;

BLOOD TRANSFUSION; CASE REPORT; HEMOLYTIC ANEMIA; HUMAN; INFANT DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LETTER; MALE; NEWBORN; PRIORITY JOURNAL;

EID: 36148944432     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070741     Document Type: Letter

References (5)

1. Vermeire S, Noman M, Van Assche G, et al. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology 2003;125:32-9.
2. Bobbio-Pallavicini F, Alpini C, Caporali R, Avalle S, Bugatti S, Montecucco C. Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. Arthritis Res Ther 2004;6:R264-R272.
3. DePalma L, Criss VR, Roseff SD, Luban NLC. Presence of the red cell alloantibody anti-E in an 11-week-old infant. Transfusion 1992;32:177-9.
4. Albiero AL, Novaretti MCZ, Llacer PED, Chamone DAF. Early primary immune response against erythrocytes: a case report. Transfus Med 2003;13:93-7.
5. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006;46:1526-36.